MetaVia Inc. (MTVA) Financials

MTVA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 13.3 million 6.4 million
March 31, 2026 14.4 million 5.3 million
Dec. 31, 2025 69.1 million 63.8 million
Sept. 30, 2025 14.8 million 8.4 million

MTVA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.8 million 130000
March 31, 2026 -4.3 million 100000
Dec. 31, 2025 -4.9 million 71000
Sept. 30, 2025 -3.0 million 97000

MTVA Net Income

No data available :(

MTVA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 12.6 million - 177000
March 31, 2026 13.7 million - 123000
Dec. 31, 2025 10.3 million - 142000
Sept. 30, 2025 14.3 million - 79000

MTVA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 5.9 million
March 31, 2026 4.9 million
Dec. 31, 2025 2.3 million
Sept. 30, 2025 2.2 million

MTVA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.5 million 1.9 million -
March 31, 2026 - 2.1 million 1.9 million -
Dec. 31, 2025 - 241000 1.8 million -
Sept. 30, 2025 - 1.9 million 1.6 million -

MTVA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 5000
Dec. 31, 2025 - 5000
Sept. 30, 2025 - -

MTVA

Price: $1.29

52 week price:
0.97
14.85

Earnings Per Share: -2.44 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 10.1 million

Links: